The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
Open accessAbstract
Although metformin is widely used for the treatment of non-insulin-dependent diabetes, its mode of action remains unclear. Here we provide evidence that its primary site of action is through a direct inhibition of complex 1 of the respiratory chain. Metformin (50 μM) inhibited mitochondrial oxidation of glutamate+malate in hepatoma cells by 13 and 30% after 24 and 60 h exposure respectively, but succinate oxidation was unaffected. Metformin also caused time-dependent inhibition of complex 1 in isolated mitochondria, whereas in sub-mitochondrial particles inhibition was immediate but required very high metformin concentrations (K0.5, 79 mM). These data are compatible with the slow membrane-potential-driven accumulation of the positively charged drug within the mitochondrial matrix leading to inhibition of complex 1. Metformin inhibition of gluconeogenesis from L-lactate in isolated rat hepatocytes was also time- and concentration-dependent, and accompanied by changes in metabolite levels similar to those induced by other inhibitors of gluconeogenesis acting on complex 1. Freeze-clamped livers from metformin-treated rats exhibited similar changes in metabolite concentrations. We conclude that the drug's pharmacological effects are mediated, at least in part, through a time-dependent, self-limiting inhibition of the respiratory chain that restrains hepatic gluconeogenesis while increasing glucose utilization in peripheral tissues. Lactic acidosis, an occasional side effect, can also be explained in this way.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin may cause lactic acidosis through impairment of oxidative phosphorylation.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [464]
In the citing paper
“it has been shown to accumulate in mitochondria due to the membrane potential across the mitochondrial inner membrane”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Owen et al. 2000
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Owen et al., 2000
In the citing paper
“This inhibition would in turn decrease the ATP/AMP ratio activating AMPK (127–129).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“As pointed out by Fontaine, a problem associated with accepting the argument that the therapeutic effects of metformin result from inhibition of complex 1, as depicted in Figure 1, are the high concentrations used in the cell culture studies described by El Mir et al. and Owen et al. (127, 128, 133).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [128]
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [210]
Citations
Cites
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Ebert, B. L., Firth, J. D., & Ratcliffe, P. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29083 · Cited by 569
Accumulation of Metformin by Tissues of the Normal and Diabetic Mouse
Wilcock, C., & Bailey, C. J. (1994) · Xenobiotica · doi:10.3109/00498259409043220 · Cited by 418
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227
Argaud, D., Roth, H., Wiernsperger, N. F., & Leverve, X. M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17886.x · Cited by 151
Biguanide-associated lactic acidosis. Case report and review of the literature
Gan, S. C. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.11.2333 · Cited by 129
Halestrap, A. P. (1987) · Biochemical Journal · doi:10.1042/bj2440159 · Cited by 120
Self-citationFischer, Y., Thomas, J., Rosen, P., & Kammermeier, H. (1995) · Endocrinology · doi:10.1210/endo.136.2.7835271 · Cited by 114
Cited by
Sorted by citations
Items 301–400 of 1,008
Gormsen, L. C., Sundelin, E. I. O., Jensen, J., Vendelbo, M. H., Jakobsen, S., Munk, O. L., Christensen, M. M. H., Brøsen, K., Frøkiær, J., & Jessen, N. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.177774 · Cited by 146
Synergistic Anti-Cancer Effect of Phenformin and Oxamate
Miskimins, W. K., Ahn, H. J., Kim, J. Y., Ryu, S., Jung, Y., & Choi, J. Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085576 · Cited by 144
Metformin and other antidiabetic agents in renal failure patients
Lalau, J., Arnouts, P., Sharif, A., & Broe, M. E. D. (2014) · Kidney International · doi:10.1038/ki.2014.19 · Cited by 147
Marini, C., Salani, B., Massollo, M., Amaro, A. A., Esposito, A. I., Orengo, A. M., Capitanio, S., Emionite, L., Riondato, M., Bottoni, G., et al. (2013) · Cell Cycle · doi:10.4161/cc.26461 · Cited by 145
Metabolic Roles of AMPK and Metformin in Cancer Cells
Choi, Y. K., & Park, K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0169-8 · Cited by 150
Johanns, M., Lai, Y., Hsu, M. F., Jacobs, R., Vertommen, D., Sande, J. V., Dumont, J. E., Woods, A., Carling, D., Hue, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms10856 · Cited by 146
Xu, Z., Feng, W., Shen, Q., Yu, N., Yu, K., Wang, S., Chen, Z., Shioda, S., & Guo, Y. (2017) · Aging and Disease · doi:10.14336/ad.2016.0620 · Cited by 148
Cellular energy sensing and signaling by AMP-activated protein kinase
Winder, W. W., & Thomson, D. M. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0008-7 · Cited by 142
Targeting the Metabolic Plasticity of Multiple Myeloma with FDA-Approved Ritonavir and Metformin
Dalva-Aydemir, S., Bajpai, R., Martinez, M. S., Adekola, K., Kandela, I. K., Wei, C., Singhal, S., Koblinski, J. E., Raje, N. S., Rosen, S. T., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1088 · Cited by 145
A Compendium of Genetic Modifiers of Mitochondrial Dysfunction Reveals Intra-organelle Buffering
To, T., Cuadros, A. M., Shah, H., Hung, W. H. W., Yang, L., Kim, S. H., Rubin, D. H. F., Boe, R. H., Rath, S. P., Eaton, J. K., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.032 · Cited by 141
Metformin for aging and cancer prevention
Anisimov, V. N. (2010) · Aging · doi:10.18632/aging.100230 · Cited by 142
Metformin‐associated lactic acidosis ( MALA ): M oving towards a new paradigm
Lalau, J., Kajbaf, F., Protti, A., Christensen, M. M. H., Broe, M. E. D., & Wiernsperger, N. F. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12974 · Cited by 143
Fogarty, S., Hawley, S. A., Green, K. A., Saner, N., Mustard, K. J., & Hardie, D. G. (2009) · Biochemical Journal · doi:10.1042/bj20091372 · Cited by 146
Morandi, A., Taddei, M. L., Chiarugi, P., & Giannoni, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00040 · Cited by 146
Serine deprivation enhances antineoplastic activity of biguanides
Gravel, S.-P., Hulea, L., Toban, N., Birman, E., Blouin, M.-J., Zakikhani, M., Zhao, Y., Topisirovic, I., St-Pierre, J., & Pollak, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2643-t · Cited by 138
Ischemic A/D transition of mitochondrial complex I and its role in ROS generation
Dröse, S., Степанова, А., & Galkin, A. S. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2015.12.013 · Cited by 140
Targeting mitochondria in cancer: current concepts and immunotherapy approaches
Pustylnikov, S., Costabile, F., Beghi, S., & Facciabene, A. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.013 · Cited by 142
Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain
Ruegsegger, G. N., Vanderboom, P. M., Dasari, S., Klaus, K. A., Kabiraj, P., McCarthy, C. B., Lucchinetti, C. F., & Nair, K. S. (2019) · JCI Insight · doi:10.1172/jci.insight.130681 · Cited by 141
Smith, A. L. M., Whitehall, J. C., Bradshaw, C., Gay, D. M., Robertson, F. M., Blain, A. P., Hudson, G., Pyle, A., Houghton, D., Hunt, M., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00112-5 · Cited by 140
Schuler, K., Rambally, B. S., DiFurio, M. J., Sampey, B. P., Gehrig, P. A., Makowski, L., & Bae-Jump, V. L. (2014) · Cancer Medicine · doi:10.1002/cam4.353 · Cited by 137
Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
Luo, X., Wu, J., Jing, S., & Yan, L. (2016) · Aging and Disease · doi:10.14336/ad.2015.0702 · Cited by 145
The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?
Vara‐Ciruelos, D., Russell, F. M., & Hardie, D. G. (2019) · Open Biology · doi:10.1098/rsob.190099 · Cited by 140
Semisynthetic biosensors for mapping cellular concentrations of nicotinamide adenine dinucleotides
Sallin, O., Reymond, L., Gondrand, C., Raith, F., Koch, B., & Johnsson, K. (2018) · eLife · doi:10.7554/elife.32638 · Cited by 137
Kefas, B. A., Cai, Y., Kerckhofs, K., Ling, Z., Martens, G. A., Heimberg, H., PIPELEERS, D. G., & de Casteele, M. V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.003 · Cited by 136
The intersection of metformin and inflammation
Bharath, L. P., & Nikolajczyk, B. S. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00604.2020 · Cited by 134
Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation
Hou, W., Yin, J., Alimujiang, M., Xue-ying, Y., Ai, L., Bao, Y., Liu, F., & Jia, W. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13432 · Cited by 140
Marino, A., Hausenloy, D. J., Andreadou, I., Horman, S., Bertrand, L., & Beauloye, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.047 · Cited by 140
Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis
Justo, R., Boada, J., Frontera, M., Oliver, J., Bermúdez, J., & Gianotti, M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00035.2005 · Cited by 133
Metformin use and endometrial cancer survival
Nevadunsky, N. S., Arsdale, A. V., Strickler, H. D., Moadel, A. B., Kaur, G., Frimer, M., Conroy, E. M., Goldberg, G. L., & Einstein, M. H. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.10.026 · Cited by 134
Yasmeen, A., Beauchamp, M.-C., Piura, E., Segal, E., Pollak, M., & Gotlieb, W. H. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.02.021 · Cited by 135
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Lord, S., & Harris, A. L. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02204-2 · Cited by 139
Zhou, X., Cao, Y., Ao, G., Hu, L., Liu, H., Wu, J. H., Wang, X., Jin, M., Zheng, S., Zhen, X., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5587 · Cited by 132
Scotland, S., Saland, E., Skuli, N., de Toni, F., Boutzen, H., Micklow, E., Sénégas, I., Peyraud, R., Peyriga, L., Théodoro, F., et al. (2013) · Leukemia · doi:10.1038/leu.2013.107 · Cited by 149
DeFronzo, R. A., Buse, J. B., Kim, T., Burns, C. M., Skare, S., Baron, A., & Fineman, M. S. (2016) · Diabetologia · doi:10.1007/s00125-016-3992-6 · Cited by 135
Metformin acutely lowers blood glucose levels by inhibition of intestinal glucose transport
Horakova, O., Kroupova, P., Bardová, K., Buresova, J., Janovská, P., Kopecký, J., & Rossmeisl, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-42531-0 · Cited by 138
Bremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 135
van Leeuwen, N., Nijpels, G., Becker, M. L., Deshmukh, H., Zhou, K., Stricker, B. H. C., Uitterlinden, A. G., Albert Hofman, D., Riet, E. V. ‘., Palmer, C. N. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2537-x · Cited by 133
Mogavero, A., Maiorana, M. V., Zanutto, S., Varinelli, L., Bozzi, F., Belfiore, A., Volpi, C. C., Gloghini, A., Pierotti, M. A., & Gariboldi, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-16149-z · Cited by 132
Metformin use in pregnancy: promises and uncertainties
Lindsay, R. S., & Loeken, M. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4351-y · Cited by 131
Choo, H. J., Saafir, T. B., Mkumba, L. S., Wagner, M. B., & Jobe, S. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300433 · Cited by 132
The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats
Vilela, D. D., Peixoto, L. G., Teixeira, R. R., Baptista, N. B., Caixeta, D. C., de Souza, A. V., Machado, H. L., Pereira, M. N., Silva, R. S., & Espíndola, F. S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6978625 · Cited by 134
Metformin Uniquely Prevents Thrombosis by Inhibiting Platelet Activation and mtDNA Release
Xin, G., Wei, Z., Ji, C., Zheng, H., Gu, J., Ma, L., Huang, W., Morris-Natschke, S. L., Yeh, J., Zhang, R., et al. (2016) · Scientific Reports · doi:10.1038/srep36222 · Cited by 129
Chowdhury, A. R., Zielonka, J., Kalyanaraman, B., Hartley, R. C., Murphy, M. P., & Avadhani, N. G. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101606 · Cited by 129
Metformin, cancer and glucose metabolism
Salani, B., Río, A. D., Marini, C., Sambuceti, G., Cordera, R., & Maggi, D. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0284 · Cited by 129
Structural basis of mammalian respiratory complex I inhibition by medicinal biguanides
Bridges, H. R., Blaza, J. N., Yin, Z., Chung, I., Pollak, M., & Hirst, J. (2023) · Science · doi:10.1126/science.ade3332 · Cited by 130
Lactic Acidosis: Recognition, Kinetics, and Associated Prognosis
Vernon, C., & LeTourneau, J. L. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2009.12.007 · Cited by 125
Metformin in breast cancer: preclinical and clinical evidence
De, A., & Kuppusamy, G. (2019) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2019.06.003 · Cited by 126
Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin
Song, S., Andrikopoulos, S., Filippis, C., Thorburn, A. W., Khan, D., & Proietto, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e275 · Cited by 122
Hasan, A. A., Madkor, H., & Wageh, S. (2013) · Drug Delivery · doi:10.3109/10717544.2013.779332 · Cited by 122
Metformin and berberine, two versatile drugs in treatment of common metabolic diseases
Wang, H., Zhu, C., Ying, Y., Luo, L., Huang, D., & Luo, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.20807 · Cited by 124
Kamel, K. S., Oh, M. S., & Halperin, M. L. (2019) · Kidney International · doi:10.1016/j.kint.2019.08.023 · Cited by 128
Fridlyand, L. E., & Philipson, L. H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1363.019 · Cited by 122
Targeting mitochondria for cancer therapy
Hockenbery, D. M. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20552 · Cited by 124
Morgillo, F., Sasso, F. C., Corte, C. M. D., Vitagliano, D., D’Aiuto, E., Troiani, T., Martinelli, E., Vita, F. D., Orditura, M., Palma, R. D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2777 · Cited by 121
Mitochondrial Complex I Activity Is Required for Maximal Autophagy
Thomas, H. E., Zhang, Y., Stefely, J. A., Veiga, S. R., Thomas, G., Kozma, S. C., & Mercer, C. A. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.101 · Cited by 123
ESFAHANIAN, N., SHAKIBA, Y., NIKBIN, B., SORAYA, H., MALEKI-DIZAJI, N., GHAZI-KHANSARI, M., & GARJANI, A. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.753 · Cited by 120
Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism
Cuyàs, E., Fernández‐Arroyo, S., Verdura, S., Garcia, R., Štursa, J., Werner, L., Blanco‐González, E., Montes‐Bayón, M., Joven, J., Viollet, B., et al. (2017) · Oncogene · doi:10.1038/onc.2017.367 · Cited by 121
Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
Emmings, E., Mullany, S. A., Chang, Z., Landen, C. N., Linder, S. T., & Bazzaro, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010229 · Cited by 122
AMPK Regulates ER Morphology and Function in Stressed Pancreatic β-Cells via Phosphorylation of DRP1
Wikström, J. D., Israeli, T., Bachar-Wikström, E., Swisa, A., Ariav, Y., Waiss, M., Kaganovich, D., Dor, Y., Cerasi, E., & Leibowitz, G. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1109 · Cited by 123
AMPK: a therapeutic target of heart failure—not only metabolism regulation
Li, X., Liu, J., Lü, Q., Ren, D., Sun, X., Rousselle, T. V., Tan, Y., & Li, J. (2018) · Bioscience Reports · doi:10.1042/bsr20181767 · Cited by 122
Energy disruptors: rising stars in anticancer therapy?
Bost, F., Poullot, A. G., Tanti, J., & Clavel, S. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.46 · Cited by 119
Hypothalamic AMPK and energy balance
López, M. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12996 · Cited by 117
Metabolic acidosis in the intensive care unit
Gauthier, P. M., & Szerlip, H. M. (2002) · Critical Care Clinics · doi:10.1016/s0749-0704(01)00012-4 · Cited by 117
Biochemical Genetic Pathways that Modulate Aging in Multiple Species: Figure 1.Preprint
Bitto, A., Wang, A. M., Bennett, C. F., & Kaeberlein, M. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025114 · Cited by 122
Pollak, M. (2014) · Nature Medicine · doi:10.1038/nm.3596 · Cited by 115
Haugrud, A. B., Zhuang, Y., Coppock, J. D., & Miskimins, W. K. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3128-y · Cited by 115
Efficient delivery of siRNA using dendritic poly(l-lysine) for loss-of-function analysis
Inoue, Y., Kurihara, R., Tsuchida, A., Hasegawa, M., Nagashima, T., Mori, T., Niidome, T., Katayama, Y., & Okitsu, O. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.022 · Cited by 119
Demaré, S., Kothari, A., Calcutt, N. A., & Fernyhough, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1847645 · Cited by 117
Mitochondrial metabolism-mediated redox regulation in cancer progression
Boese, A. C., & Kang, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101870 · Cited by 114
Zhang, L., He, H., & Balschi, J. A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00002.2007 · Cited by 116
Shi, Y. (2010) · Journal of Biomedical Research · doi:10.1016/s1674-8301(10)60003-6 · Cited by 119
Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
Hadad, S. M., Hardie, D. G., Appleyard, V., & Thompson, A. M. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1144-8 · Cited by 113
Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I
Brunmair, B., Lest, A., Staniek, K., Gras, F., Scharf, N., Roden, M., Nohl, H., Waldhäusl, W. K., & Fürnsinn, C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068312 · Cited by 114
Kim, K. H., Jeong, Y. T., Kim, S. H., Jung, H. S., Park, K. S., Lee, H.-Y., & Lee, M.-S. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.026 · Cited by 112
The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes
Martin, S. D., & McGee, S. L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.09.019 · Cited by 117
Vázquez‐Manrique, R. P., Farina, F., Cambon, K., Sequedo, M. D., Parker, J. A., Millán, J. M., Weiss, A., Déglon, N., & Néri, C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv513 · Cited by 119
Wu, Z., Sun, H., Wang, C., Liu, W., Liu, M., Zhu, Y., Xu, W., Jin, H. Z., & Li, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.04.017 · Cited by 113
Wessels, B., Čiapaitė, J., van den Broek, N. M. A., Nicolay, K., & Prompers, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100525 · Cited by 112
Profiling metabolic networks to study cancer metabolism
Hiller, K., & Metallo, C. M. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.11.001 · Cited by 113
Towards natural mimetics of metformin and rapamycin
Aliper, A. M., Jellen, L. C., Cortese, F., Artemov, A. V., Karpinsky‐Semper, D., Moskalev, A., Swick, A. G., & Zhavoronkov, A. A. (2017) · Aging · doi:10.18632/aging.101319 · Cited by 112
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 114
A review of phenformin, metformin, and imeglimin
Yendapally, R., Sikazwe, D., Kim, S. S., Ramsinghani, S., Fraser‐Spears, R., Witte, A. P., & Viola, B. L. (2020) · Drug Development Research · doi:10.1002/ddr.21636 · Cited by 111
Neither LKB1 Nor AMPK Are the Direct Targets of Metformin
Hardie, D. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.032 · Cited by 113
Cellular Responses to the Metal-Binding Properties of Metformin
Logie, L., Harthill, J. E., Patel, K., Bacon, S., Hamilton, D. L., Macrae, K., McDougall, G. J., Wang, H., Xue, L., Jiang, H., et al. (2012) · Diabetes · doi:10.2337/db11-0961 · Cited by 113
Nederlof, R., Eerbeek, O., Hollmann, M. W., Southworth, R., & Zuurbier, C. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12363 · Cited by 113
Ewart, M., & Kennedy, S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.11.002 · Cited by 112
Allison, K. E., Coomber, B. L., & Bridle, B. W. (2017) · Immunology · doi:10.1111/imm.12777 · Cited by 109
Hirsch, A., Hahn, D., Kempná, P., Hofer, G., Nuoffer, J.-M., Mullis, P. E., & Flück, C. E. (2012) · Endocrinology · doi:10.1210/en.2012-1145 · Cited by 109
Zhuang, Y., & Miskimins, W. K. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0343 · Cited by 113
Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism
Meneses, M. J., Silva, B. M., Sousa, M., Sá, R., Oliveira, P. F., & Alves, M. G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710145753 · Cited by 112
Anti-Diabetic Effect of Portulaca oleracea L. Polysaccharideandits Mechanism in Diabetic Rats
Bai, Y., Zang, X., Ma, J., & Xu, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081201 · Cited by 109
The multiple links between actin and mitochondria
Fung, T. S., Chakrabarti, R., & Higgs, H. N. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00613-y · Cited by 112
Chen, L., Wang, J., You, Q., He, S., Meng, Q., Gao, J., Wu, X., Shen, Y., Sun, Y., Wu, X., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00761 · Cited by 108
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Fruci, B., Giuliano, S., Mazza, A., Malaguarnera, R., & Belfiore, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141122933 · Cited by 109
Targeting LKB1 signaling in cancer
Korsse, S. E., Peppelenbosch, M. P., & van Veelen, W. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.006 · Cited by 107
Sivalingam, V. N., Myers, J., Nicholas, S., Balen, A. H., & Crosbie, E. J. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu037 · Cited by 113
The LKB1 tumor suppressor kinase in human disease
Katajisto, P., Vallenius, T., Vaahtomeri, K., Ekman, N., Udd, L., Tiainen, M., & Mäkelä, T. P. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.003 · Cited by 113
Whittington, H. J., Hall, A. R., McLaughlin, C., Hausenloy, D. J., Yellon, D. M., & Mocanu, M. M. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6425-x · Cited by 108
Ppm1E is an in cellulo AMP-activated protein kinase phosphatase
Voß, M., Paterson, J., Kelsall, I. R., Martín‐Granados, C., Hastie, C. J., Peggie, M. W., & Cohen, P. T. W. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.08.010 · Cited by 111
Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts
Leclerc, G. M., Leclerc, G. J., Kuznetsoff, J. N., DeSalvo, J., & Barredo, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074420 · Cited by 111
Metadata
- Authors
- OWEN, M. R., DORAN, E., & HALESTRAP, A. P.
- Affiliations
- University of Bristol (GB)
- ORCID
- HALESTRAP, Andrew P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2000-06-07
- Volume
- 348
- Issue
- 3
- Pages
- 607-614
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1221104
- OpenAlex
- W1995069275
- Cited by
- 2,157
- References
- 35
- Citations by year
- 2026: 64 · 2025: 78 · 2024: 92 · 2023: 125 · 2022: 127 · 2021: 157 · 2020: 163 · 2019: 144 · 2018: 142 · 2017: 144 · 2016: 139 · 2015: 126 · 2014: 135 · 2013: 112 · 2012: 75
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, mitochondrial complex I inhibition, mitochondrial respiratory chain, type 2 diabetes, gluconeogenesis, hepatocytes, mitochondrial membrane potential, lactic acidosis, glucose utilization, mechanism of action
- MeSH terms
- Animals, Electron Transport, Gluconeogenesis, Hypoglycemic Agents, Liver, Male, Metformin, Mitochondria, NADH, NADPH Oxidoreductases, Submitochondrial Particles, Tumor Cells, Cultured, Signal Transduction, Rats, Wistar, Electron Transport Complex I, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
